Jereme M. Sylvain

Chief Accounting Officer, NuVasive.

Companies

  • DexcomSVP, Finance & CAO Mar 10, 2020 to now1
  • DexcomChief financial officer May 26, 2021 to Jun 11, 20242
  • NuVasiveChief Accounting Officer Aug 3, 2016 to Feb 5, 20183

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • Dexcom DXCM146,828 shares4$12.6M at $86.09Sep 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

  • Sep 10, 2026Sold 3,638 shares at $83.27 of Dexcom4
  • Aug 22, 2026Shares withheld for tax 1,451 shares at $92.34 of Dexcom5
  • May 22, 2026Shares withheld for tax 1,451 shares at $71.90 of Dexcom6
  • Mar 8, 2026Shares withheld for tax 18,950 shares at $68.10 of Dexcom7
  • Mar 8, 2026Granted 48,774 shares of Dexcom7
  • Jan 29, 2026Shares withheld for tax 2,652 shares at $73.36 of Dexcom8
  • Jan 29, 2026Granted 7,123 shares of Dexcom8
  • Sep 2, 2025Sold 4,824 shares at $74.17 of Dexcom9
  • Mar 12, 2025Sold 12,001 shares at $70.38 of Dexcom10
  • Mar 10, 2025Sold 1,127 shares at $74.70 of Dexcom11
  • Mar 10, 2025Sold 3,203 shares at $74.04 of Dexcom11
  • Mar 10, 2025Sold 2,670 shares at $73.22 of Dexcom11
  • Mar 8, 2025Granted 22,798 shares of Dexcom11
  • Mar 8, 2025Granted 35,906 shares of Dexcom11
  • Jan 29, 2025Sold 2,090 shares at $86.91 of Dexcom12
  • Jan 28, 2025Granted 5,586 shares of Dexcom12
  • Dec 16, 2024Sold 744 shares at $76.87 of Dexcom13
  • Nov 15, 2024Sold 3,500 shares at $75.51 of Dexcom14
  • Sep 9, 2024Sold 746 shares at $69.15 of Dexcom15
  • Jun 10, 2024Sold 745 shares at $115.05 of Dexcom16
  • Mar 12, 2024Sold 11,661 shares at $134.41 of Dexcom17
  • Mar 8, 2024Granted 26,053 shares of Dexcom18
  • Feb 20, 2024Sold 3,363 shares at $116.73 of Dexcom19
  • Jan 16, 2024Sold 2,734 shares at $123.63 of Dexcom20
  • Jan 12, 2024Granted 7,171 shares of Dexcom20